Screener
Viking Therapeutics VKTX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The source filing: Viking Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 29, 2026, 9:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-193315
FAQ
- What is Viking Therapeutics's net change in cash?
- Viking Therapeutics (VKTX) reported net change in cash of -$47.71M in Q1 2026.
- How has Viking Therapeutics's net change in cash changed year-over-year?
- Viking Therapeutics's net change in cash decreased by 523.6% year-over-year, from $11.26M to -$47.71M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Viking Therapeutics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude